secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLIGENIX, INC. (SNGX)
CIK:        0000812796
Form:       8-K
Filed at:   2023-04-19T23:59:59+00:00
Accession:  0001558370-23-006237
Event type: debt
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Soligenix amends loan with Pontifax; repays $5M; reduces minimum cash covenant to $1.5M
--------------------------------------------------------------------------------

- Repaid $5M of $8M loan principal, leaving $3M outstanding; prepayment premium eliminated.
- Minimum cash covenant reduced from $4.5M to $1.5M; falls to $0 if $10M raised by Dec 31, 2023.
- Conversion price set at 90% of prior day's close for first 588,599 shares; $1.70 thereafter.
- FDA refusal to file HyBryte NDA triggered an Event of Default, waived until Dec 31, 2023 if $5.6M raised.
- Interest-only period extended to Dec 31, 2023 if $5.6M raised; to June 30, 2024 if $10M raised.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/812796/000155837023006237/0001558370-23-006237-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/812796/000155837023006237/sngx-20230419x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-006237

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer